Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2010
05/11/2010US7714207 Inbred corn line LEP20
05/11/2010US7714206 Inbred corn line LLR24
05/11/2010US7714204 Inbred corn line 5RQ675
05/11/2010US7714203 Inbred corn line BE9513
05/11/2010US7714190 GTP binding stress-related proteins and methods of use in plants
05/11/2010US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010US7714107 Freeze-dried fibrin matrices and methods for preparation thereof
05/11/2010US7714106 Neuropeptides and their use for pest control
05/11/2010US7714104 Methods for inhibiting immune complex formation in a subject
05/11/2010US7714102 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors; treatment of cancer and bone growth
05/11/2010US7713933 Pharmaceutical composition containing an activin or inhibin stimulator
05/11/2010US7713932 Calcitonin drug-oligomer conjugates, and uses thereof
05/11/2010US7713929 fusion protein contains a rapid or intermediate acting insulin in combination with a long acting insulin; administered before breakfast, it covers the meal, does not produce hypoglycemia after the meal and provides adequate basal insulin for 24 hours
05/11/2010US7713925 Syndecans and angiogenesis
05/11/2010US7713923 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair
05/11/2010US7713915 cloning; ribosome inactivating protein
05/11/2010US7713737 delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker
05/11/2010US7713721 Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
05/11/2010US7713713 Polypeptide having intracellular calcium ion indicator function
05/11/2010US7713710 Isolation and use of solid tumor stem cells
05/11/2010US7713707 Process for protein extraction
05/11/2010US7713699 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders
05/11/2010US7713534 Streptococcus pneumoniae proteins and nucleic acid molecules
05/11/2010US7713532 isolated hepatitis B virus (HBV) core-like particle comprising an HBV precore protein, and further not comprising HBV DNA ; vaccines; assay kit comprising an anionic surfactant and an antibody that recognizes amino acids at positions -28 to 150 of the HBV precore protein
05/11/2010US7713531 Protein, a gene encoding therefor and a method of using the same
05/11/2010US7713530 HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713521 MCP1 fusions
05/11/2010US7713351 Method for crystallization of proteins using polysaccharides
05/11/2010CA2434512C Marker for inflammatory conditions
05/11/2010CA2395254C Branched polyalkylene glycols
05/11/2010CA2392722C Male tissue-preferred regulatory region and method of using same
05/11/2010CA2366231C One step sample preparation and detection of nucleic acids in complex biological samples
05/11/2010CA2348739C Methods of conversion of interferon isoforms and products thereof
05/11/2010CA2344506C Method for the production of recombinant peptides with a low amount of trisulfides
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/11/2010CA2254866C Methods for creating transgenic animals
05/11/2010CA2205237C Pesticidal composition comprising cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/11/2010CA2180965C Influenza vaccine
05/11/2010CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/10/2010CA2780482A1 Hdl particles for delivery of nucleic acids
05/08/2010CA2738644A1 Hepatitis c antibodies and uses thereof
05/06/2010WO2010051347A1 A method for cardioprotection
05/06/2010WO2010051335A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
05/06/2010WO2010051274A2 Fibronectin type iii domain based scaffold compositions, methods and uses
05/06/2010WO2010050939A1 Improved hcv vaccines and methods for using the same
05/06/2010WO2010050903A1 Chimeric flagellins for vaccines
05/06/2010WO2010050513A1 Polypeptide having function to increase calcium concentration in osteoblast
05/06/2010WO2010050485A1 Refolding agents and protein refolding method
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2010049688A1 Leukolectins and uses thereof
05/06/2010WO2010049488A1 Treating diabetes melitus using insulin injections with less than daily injection frequency
05/06/2010WO2010049177A1 Novel tools for the production of glycosylated proteins in host cells
05/06/2010WO2010049103A1 Soluble truncated apom proteins and medical uses thereof
05/06/2010WO2010048941A2 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic
05/06/2010WO2010030992A3 Novel plasmodium falciparum gene encoding signal peptide peptidase and methods of using inhibitors thereof for inhibiting malarial infection
05/06/2010WO2010029278A3 Isolation and identification of glycosaminoglycans
05/06/2010WO2010028999A3 Production of infectious hepatitis c virus particles in cell culture
05/06/2010WO2010027827A3 Targeted costimulatory polypeptides and methods of use to treat cancer
05/06/2010WO2010027423A3 Compositions of pd-1 antagonists and methods of use
05/06/2010WO2010026219A3 New tomato ethylene response factors and uses thereof
05/06/2010WO2010021846A3 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae
05/06/2010WO2010019103A9 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer
05/06/2010WO2010017653A8 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
05/06/2010WO2010016766A3 Antibodies recognizing endogenous human lgr5 and/or lgr6
05/06/2010WO2010016067A3 Affinity purification by cohesin-dockerin interaction
05/06/2010WO2010014922A3 Protein purification tags and uses thereof
05/06/2010WO2010006136A3 Adenovirus targeting
05/06/2010WO2009149171A4 Fgf21 mutants and uses thereof
05/06/2010WO2009094218A9 Novel cell lines expressing nav and methods using them
05/06/2010WO2009039413A8 Methods and compositions for detection of ehrlichia chaffeensis (p120)
05/06/2010WO2007081301A3 Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii
05/06/2010US20100115669 Plant Cyclopropane Fatty Acid Synthase Genes, Proteins, And Uses Thereof
05/06/2010US20100115667 Novel At1g67330 gene involved in altered nitrate uptake efficiency
05/06/2010US20100113755 Isolated modified human chorionic gonadotropin proteins
05/06/2010US20100113754 Method for producing antithrombin composition
05/06/2010US20100113750 Novel scavenger receptor
05/06/2010US20100113749 Novel scavenger receptor
05/06/2010US20100113748 Soluble il-17rcx4 and methods of using in inflammation
05/06/2010US20100113744 Stabilization Of Liquid Solutions Of Recombinant Protein For Frozen Storage
05/06/2010US20100113743 Glycopegylated factor vii and factor viia
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113741 Composition, method and use of bi-functional biomaterials
05/06/2010US20100113740 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
05/06/2010US20100113605 Methods, compositions and uses thereof
05/06/2010US20100113582 Methods and compositions for treating hiv infections
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113470 Bcr-abl variants
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113398 Treatment and/or Prevention of Non-Viral Epithelial Damage
05/06/2010US20100113369 Means for preventing and treating cellular death and their biological applications
05/06/2010US20100113363 Use of GLP-1 Peptides
05/06/2010US20100113362 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113356 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
1 ... 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 ... 2916